L-DOPA Is an Endogenous Ligand for OA1

por Lopez, Vanessa M, Decatur, Christina L, Stamer, W. Daniel, Lynch, Ronald M, McKay, Brian S
Publicado 2008

PieParty: visualizing cells from scRNA-seq data as pie charts

por Kurtenbach, Stefan, Dollar, James J, Cruz, Anthony M, Durante, Michael A, Decatur, Christina L, Harbour, J William
Publicado en Life Sci Alliance (2021)

Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment

por Houston, Samuel K, Shah, Nisha V, Decatur, Christina, Lonngi, Marcela, Feuer, William, Markoe, Arnold M, Murray, Timothy G
Publicado 2013

Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes

por Decatur, Christina L., Ong, Erin, Garg, Nisha, Anbunathan, Hima, Bowcock, Anne M., Field, Matthew G., Harbour, J. William
Publicado en JAMA Ophthalmol (2016)

Impact of Genetic Ancestry on Prognostic Biomarkers in Uveal Melanoma

por Rodriguez, Daniel A., Sanchez, Margaret I., Decatur, Christina L., Correa, Zelia M., Martin, Eden R., Harbour, J. William
Publicado en Cancers (Basel) (2020)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma

por Lonngi, Marcela, Houston, Samuel K, Murray, Timothy G, Sisk, Robert A, Decatur, Christina L, Cavalcante, Milena, Markoe, Arnold M
Publicado 2013

Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma

por Cai, Louis, Paez-Escamilla, Manuel, Walter, Scott D., Tarlan, Bercin, Decatur, Christina L., Perez, Barbara M., Harbour, J. William
Publicado en Am J Ophthalmol (2018)

Intraocular Dissemination of Uveal Melanoma Cells Following Radiotherapy: Evolving Management Over the Past Decade

por Paez-Escamilla, Manuel, Walter, Scott D., Mohsenin, Amir, Decatur, Christina L., Harocopos, George J., Dubovy, Sander, Harbour, J. William
Publicado en Ophthalmic Surg Lasers Imaging Retina (2019)

Genomic evolution of uveal melanoma arising in ocular melanocytosis

por Durante, Michael A., Field, Matthew G., Sanchez, Margaret I., Covington, Kyle R., Decatur, Christina L., Dubovy, Sander R., Harbour, J. William
Publicado en Cold Spring Harb Mol Case Stud (2019)

2-DEOXY-GLUCOSE DOWN REGULATES ENDOTHELIAL AKT AND ERK VIA INTERFERENCE WITH N-LINKED GLYCOSYLATION, INDUCTION OF ENDOPLASMIC RETICULUM STRESS AND GSK-3β ACTIVATION

por Kovács, Krisztina, Decatur, Christina, Toro, Marcela, Pham, Dien G., Liu, Huaping, Jing, Yuqi, Murray, Timothy G., Lampidis, Theodore J., Merchan, Jaime R.
Publicado en Mol Cancer Ther (2015)

Punctuated evolution of canonical genomic aberrations in uveal melanoma

por Field, Matthew G., Durante, Michael A., Anbunathan, Hima, Cai, Louis Z., Decatur, Christina L., Bowcock, Anne M., Kurtenbach, Stefan, Harbour, J. William
Publicado en Nat Commun (2018)

BAP1 loss is associated with DNA methylomic repatterning in highly aggressive Class 2 uveal melanomas

por Field, Matthew G., Kuznetsov, Jeffim N., Bussies, Parker L., Cai, Louie, Alawa, Karam A., Decatur, Christina L., Kurtenbach, Stefan, Harbour, J. William
Publicado en Clin Cancer Res (2019)

Retinoblastoma Treatment: Utilization of the Glycolytic Inhibitor, 2-deoxy-2-fluoro-d-glucose (2-FG), to Target the Chemoresistant Hypoxic Regions in LH(BETA)T(AG) Retinal Tumors

por Piña, Yolanda, Decatur, Christina, Murray, Timothy G., Houston, Samuel K., Lopez-Cavalcante, Milena, Hernandez, Eleut, Celdran, Magda, Shah, Nikesh, Feuer, William, Lampidis, Theodore
Publicado 2012

Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors

por Piña, Yolanda, Houston, Samuel K, Murray, Timothy G, Koru-Sengul, Tulay, Decatur, Christina, Scott, William K, Nathanson, Lubov, Clarke, Jennifer, Lampidis, Theodore J
Publicado 2012

Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations

por Durante, Michael A., Walter, Scott D., Paez-Escamilla, Manuel, Tokarev, Julian, Decatur, Christina L., Dubovy, Sander R., Schefler, Amy C., Harbour, J. William
Publicado en JAMA Ophthalmol (2019)

PRAME as an independent biomarker for metastasis in uveal melanoma

por Field, Matthew G., Decatur, Christina L., Kurtenbach, Stefan, Gezgin, Gülçin, van der Velden, Pieter A., Jager, Martine J., Kozak, Kaleigh N., Harbour, J. William
Publicado en Clin Cancer Res (2016)

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas

por Field, Matthew G., Durante, Michael A., Decatur, Christina L., Tarlan, Bercin, Oelschlager, Kristen M., Stone, John F., Kuznetsov, Jeffim, Bowcock, Anne M., Kurtenbach, Stefan, Harbour, J. William
Publicado en Oncotarget (2016)

Single-cell analysis reveals new evolutionary complexity in uveal melanoma

por Durante, Michael A., Rodriguez, Daniel A., Kurtenbach, Stefan, Kuznetsov, Jeffim N., Sanchez, Margaret I., Decatur, Christina L., Snyder, Helen, Feun, Lynn G., Livingstone, Alan S., Harbour, J. William
Publicado en Nat Commun (2020)

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis

por Cavalcante, Ludimila L, Cavalcante, Milena L, Murray, Timothy G, Vigoda, Michael M, Piña, Yolanda, Decatur, Christina L, Davis, R Prince, Olmos, Lisa C, Schefler, Amy C, Parrott, Michael B, Alliman, Kyle J, Flynn, Harry W, Moshfeghi, Andrew A
Publicado 2010